ketamine
Commercial- Indications
- Treatment-resistant depression, PTSD, Anxiety, Chronic pain, Addiction
Company intelligence / Profile preview
Lifeline Interventional Therapeutics operates as a physician-led clinic specializing in advanced ketamine-based therapies—including IV infusions and FDA-approved Spravato®—for patients with treatment-resistant depression, PTSD, anxiety, chronic pain, suicidal ideation, and addiction. The clinic emphasizes personalized care plans based on thorough psychiatric evaluation and ongoing medical management. Clinical results cited include rapid symptom relief for many patients who have failed traditional treatments.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lifeline Interventional Therapeutics.